These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 10505121)
21. Identification of the promoter of human transcription factor Sp3 and evidence of the role of factors Sp1 and Sp3 in the expression of Sp3 protein. Lou Z; Maher VM; McCormick JJ Gene; 2005 May; 351():51-9. PubMed ID: 15857802 [TBL] [Abstract][Full Text] [Related]
22. Development of murine leukemia virus-based retroviral vectors with a minimum possibility of cis-activation. Jang J; Lee JT; Lee K; Kim S; Kim JY; Yoon K; Kim S Gene Ther; 2011 Mar; 18(3):240-9. PubMed ID: 20944681 [TBL] [Abstract][Full Text] [Related]
23. Photoactivatable retroviral vectors: a strategy for targeted gene delivery. Pandori MW; Sano T Gene Ther; 2000 Dec; 7(23):1999-2006. PubMed ID: 11175311 [TBL] [Abstract][Full Text] [Related]
24. Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems. Tarantal AF; O'Rourke JP; Case SS; Newbound GC; Li J; Lee CI; Baskin CR; Kohn DB; Bunnell BA Mol Ther; 2001 Feb; 3(2):128-38. PubMed ID: 11237669 [TBL] [Abstract][Full Text] [Related]
25. Pharmacologically regulated production of targeted retrovirus from T cells for systemic antitumor gene therapy. Crittenden M; Gough M; Chester J; Kottke T; Thompson J; Ruchatz A; Clackson T; Cosset FL; Chong H; Diaz RM; Harrington K; Alvarez Vallina L; Vile R Cancer Res; 2003 Jun; 63(12):3173-80. PubMed ID: 12810645 [TBL] [Abstract][Full Text] [Related]
26. A novel doxycycline inducible autoregulatory plasmid which displays "on"/"off" regulation suited to gene therapy applications. Gould DJ; Berenstein M; Dreja H; Ledda F; Podhajcer OL; Chernajovsky Y Gene Ther; 2000 Dec; 7(24):2061-70. PubMed ID: 11223986 [TBL] [Abstract][Full Text] [Related]
27. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns. Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505 [TBL] [Abstract][Full Text] [Related]
28. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells. Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381 [TBL] [Abstract][Full Text] [Related]
29. Gene transfer into nonhuman primate hematopoietic stem cells: implications for gene therapy. Hanazono Y; Terao K; Ozawa K Stem Cells; 2001; 19(1):12-23. PubMed ID: 11209087 [TBL] [Abstract][Full Text] [Related]
30. Factors affecting the performance of different long terminal repeats in the retroviral vector. Kim S; Lee K; Kim MD; Kang S; Joo CW; Kim JM; Kim SH; Yu SS; Kim S Biochem Biophys Res Commun; 2006 May; 343(4):1017-22. PubMed ID: 16574062 [TBL] [Abstract][Full Text] [Related]
32. Gene transfer into hematopoietic cells. Nienhuis AW; Bertran J; Hargrove P; Vanin E; Yang Y Stem Cells; 1997; 15 Suppl 1():123-34. PubMed ID: 9368332 [TBL] [Abstract][Full Text] [Related]
33. The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors. Ikawa Y; Uchiyama T; Jagadeesh GJ; Candotti F Gene Ther; 2016 Nov; 23(11):815-818. PubMed ID: 27487944 [TBL] [Abstract][Full Text] [Related]
34. Efficient gene delivery to quiescent interleukin-2 (IL-2)-dependent cells by murine leukemia virus-derived vectors harboring IL-2 chimeric envelope glycoproteins. Maurice M; Mazur S; Bullough FJ; Salvetti A; Collins MK; Russell SJ; Cosset FL Blood; 1999 Jul; 94(2):401-10. PubMed ID: 10397706 [TBL] [Abstract][Full Text] [Related]
35. Inefficiency of expression of luciferase reporter from transfected murine leukaemia proviral DNA may be partially overcome by providing a strong polyadenylation signal. Maxwell IH; Brown JL; Maxwell F J Gen Virol; 1991 Jul; 72 ( Pt 7)():1721-4. PubMed ID: 1649905 [TBL] [Abstract][Full Text] [Related]
36. Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors. Moiani A; Miccio A; Rizzi E; Severgnini M; Pellin D; Suerth JD; Baum C; De Bellis G; Mavilio F PLoS One; 2013; 8(1):e55721. PubMed ID: 23383272 [TBL] [Abstract][Full Text] [Related]